Serial Number
86977316
Owner
Pinney Associates, Inc.Attorney
Joseph W. Berenato, IIIFirst Use Date
Jun 23, 2015
Filing Date
Jun 2, 2014
ALERRT Trademark
Serial Number: 86977316 • Registration: 4934252
Trademark Classes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 45 - Legal & Security Services
Legal services; security services for the protection of property and individuals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
June 2, 2014
Registration Date
April 5, 2016
First Use Anywhere
June 23, 2015
First Use in Commerce
June 23, 2015
Published for Opposition
December 30, 2014
Cancellation Date
October 21, 2022
Goods & Services
Providing comparative analysis of pharmaceuticals, namely, preparation of reports, statistical analysis, studies and ratings comparing abuse-deterrent features of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features with comparator products and similar prototype abuse-deterrent formulations; providing analysis in the field of pharmaceuticals, namely, preparation of reports, statistical analysis, studies and ratings with regard to the labor, effort and resources required to alter and or tamper with abuse-deterrent formulations and or new chemical entities with abuse-deterrent features; providing analysis in the field of pharmaceuticals, namely, preparation of reports, statistical analysis, studies and ratings with regard to the labor, effort and resources required to alter by means of tampering abuse-deterrent formulations and or new chemical entities with abuse-deterrent features
Regulatory compliance consulting services in the field of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features to ensure compliance with government standards concerning labeling, advertising and marketing, risk management and strategic communications, namely, translation of information to regulatory agencies
Consulting services in the field of pharmaceuticals, namely, quantitative assessment of drug tamperability and manipulation as it relates to abuse by various routes of drug administration; scientific and medical research and development related to pharmaceuticals formulated for abuse-deterrent applications and the abuse and diversion of pharmaceutical preparations; contract research services, namely, laboratory in vitro assessment as it relates to Food and Drug Administration Category 1 studies in the field of the alteration and tampering of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features; quality and safety management services, namely, evaluation and scientific analysis concerning the physical and chemical properties of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features; product development consultation, namely, assessment and analysis of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features as it relates to labor, effort and resources required to manipulate and alter abuse-deterrent formulations and or new chemical entities with abuse-deterrent features
